• No results found

Corrigendum to 'Editor's Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections' [European Journal of Vascular & Endovascular Surgery 59/3 (2020) 339-384]

N/A
N/A
Protected

Academic year: 2021

Share "Corrigendum to 'Editor's Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections' [European Journal of Vascular & Endovascular Surgery 59/3 (2020) 339-384]"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Corrigendum to 'Editor's Choice - European Society for Vascular Surgery (ESVS) 2020

Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections'

[European Journal of Vascular & Endovascular Surgery 59/3 (2020) 339-384]

Chakfé, Nabil; Diener, Holger; Lejay, Anne; Assadian, Ojan; Berard, Xavier; Caillon, Jocelyne;

Fourneau, Inge; Glaudemans, Andor W J M; Koncar, Igor; Lindholt, Jes

Published in:

European Journal of Vascular and Endovascular Surgery

DOI:

10.1016/j.ejvs.2020.07.080

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Chakfé, N., Diener, H., Lejay, A., Assadian, O., Berard, X., Caillon, J., Fourneau, I., Glaudemans, A. W. J.

M., Koncar, I., Lindholt, J., Melissano, G., Saleem, B. R., Senneville, E., Slart, R. H. J. A., Szeberin, Z.,

Venermo, M., Vermassen, F., Wyss, T. R., Esvs Guidelines Committee, ... Wanhainen, A. (2020).

Corrigendum to 'Editor's Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice

Guidelines on the Management of Vascular Graft and Endograft Infections' [European Journal of Vascular

& Endovascular Surgery 59/3 (2020) 339-384]. European Journal of Vascular and Endovascular Surgery,

60(6), 958. https://doi.org/10.1016/j.ejvs.2020.07.080

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the

author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately

and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the

number of authors shown on this cover page is limited to 10 maximum.

(2)

CORRIGENDUM

Corrigendum to

‘Editor’s Choice e European Society for Vascular Surgery

(ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular

Graft and Endograft Infections

’ [European Journal of Vascular &

Endovascular Surgery 59/3 (2020) 339

e384]

Nabil Chakfé*,a,e, Holger Dienera, Anne Lejaya,e, Ojan Assadiana, Xavier Berarda, Jocelyne Caillona,e, Inge Fourneaua,

Andor W.J.M. Glaudemansa,d, Igor Koncara, Jes Lindholta, Germano Melissanoa, Ben R. Saleema, Eric Sennevillea,e, Riemer H.J.A. Slarta,d,

Zoltan Szeberina, Maarit Venermoa, Frank Vermassena, Thomas R. Wyssa

ESVS Guidelines Committeeb, Gert J. de Borst, Frederico B. Gonçalves, Stavros K. Kakkos, Philippe Kolh, Riikka Tulamo, Melina V. de Ceniga

Document Reviewersc, Regula S. von Allmen, Jos C. van den Berg, E. Sebastian Debus, Mark J.W. Koelemay, Jose P. Linares-Palomino, Gregory L. Moneta, Jean-Baptiste Ricco, Anders Wanhainen

The authors regret there were mistakes in

Table 12

concerning adjusted risk estimation for surgical site infections of the

lower limbs. The authors would like to thank Dr Tresson and colleagues for their careful reading and to apologise for any

inconvenience.

Table 12

should be read as below:

Table 12.Patient related independent risk factors for surgical site infections of the lower limbs

Risk factor Adjusted risk estimation OR (95% CI) Reference

Female sex 1.44 (1.28e1.63) Greenblatt et al. (2011)278

Obesity 2.08 (1.78e2.43) Greenblatt et al. (2011)278

Body mass index 25 1.78 (1.23e2.57)

1.28 (1.10e1.49) Davis et al. (2017)

279

Greenblatt et al. (2011)278

Hypertension 4.29 (2.74e6.72) Davis et al. (2017)279

Chronic obstructive pulmonary disease 2.10 (1.07e4.09) 1.23 (1.03e1.43)

Leekha et al. (2016)280

Greenblatt et al. (2011)278

History of chronic heart failure 1.86 (1.13e3.05) Davis et al. (2017)279

Creatinine> 1.5 mg/dL 1.57 (1.09e2.27) Davis et al. (2017)279

Dialysis 1.51 (1.08e2.11)

4.35 (3.45e5.47) Greenblatt et al. (2011)

278

Davis et al. (2017)279

Critical limb ischaemia 2.91 (1.61e5.27) Leekha et al. (2016)280

Re-intervention 11.00 (1.90e63.00) Brothers et al. (2009)211

Peak glucose> 180 mg/dL 1.99 (1.53e2.57) Davis et al. (2017)279

Hyponatremia<134 g/dL 1.20 (1.02e1.42) Greenblatt et al. (2011)278

Major amputation 12.00 (4.10e34.00) Brothers et al. (2009)211

Prior revascularisation 2.68 (1.38e5.22)

1.57 (1.04e2.38) Leekha et al. (2016)

280

Davis et al. (2017)279

Any platelet medication 4.29 (3.41e5.41) Davis et al. (2017)279

For full list of Author’s affiliations, please refer to Appendix available with the original article

5The ESVS 2020 Guidelines on Management of Vascular Graft Infections are Endorsed by the European Association of Nuclear Medicine (EANM).

DOI of original article:https://doi.org/10.1016/j.ejvs.2019.10.016.

aWriting Committee: Nabil Chafké (Chair)* (Strasbourg, France), Holger Diener (Co-Chair) (Hamburg, Germany), Anne Lejay (Strasbourg, France), Ojan Assadian

(Vienna, Austria), Xavier Berard (Bordeaux, France), Jocelyne Caillon (Nantes, France), Inge Fourneau (Leuven, Belgium), Andor W.J.M. Glaudemans (Groningen, The Netherlands), Igor Koncar (Belgrade, Serbia), Jes Lindholt (Odense, Denmark), Germano Melissano (Milan, Italy), Ben R. Saleem (Groningen, The Netherlands), Eric Senneville (Tourcoing, France), Riemer H.J.A. Slart (Groningen, The Netherlands), Zoltan Szeberin (Budapest, Hungary), Omke Teebken (Peine, Germany), Maarit Venermo (Helsinki, Finland), Frank Vermassen (Ghent, Belgium), Thomas R. Wyss (Bern, Switzerland).

bESVS Guidelines Committee: Gert J. de Borst (Chair) (Utrecht, The Netherlands), Frederico Bastos Gonçalves (Lisbon, Portugal), Stavros K. Kakkos (Patras, Greece),

Philippe Kolh (Liège, Belgium), Riikka Tulamo (Helsinki, Finland), Melina Vega de Ceniga (Review coordinator) (Bizkaia, Spain).

cDocument Reviewers: Regula S. von Allmen (Gallen, Switzerland), Jos C. van den Berg (Bern, Switzerland), E. Sebastian Debus (Hamburg-Eppendorf, Germany),

Mark J.W. Koelemay (Amsterdam, The Netherlands), Jose P. Linares-Palomino (Granada, Spain), Gregory L.L. Moneta (Portland, OR, USA), Jean-Baptiste Ricco (Poitiers, France), Anders Wanhainen (Uppsala, Sweden).

dEuropean Association of Nuclear Medicine. eGroupe de Recherche sur les Infections de Prothèses.

* Corresponding author. E-mail address:nabil.chakfe@chru-strasbourg.fr(Nabil Chakfé)

1078-5884/Ó 2020 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

https://doi.org/10.1016/j.ejvs.2020.07.080

Referenties

GERELATEERDE DOCUMENTEN

The surgical procedures done on the patients in the study included common femoral reconstruction, femoro-popliteal, femoro-crural, and femoro- femoral crossover bypass

This study shows that subcuticular absorbable skin staples in peripheral vascular surgery do not decrease the number of wound complications.. The technique has positive aspects

Types of studies considered for a pooled analysis included randomized controlled trials (RCTs), and cohort studies that met the following criteria: (i) were published as full

In conclusion, the PiERO trial is a multicenter randomized controlled clinical trial designed to show the consequences of using percutaneous access in EVAR surgery, when

The objective was to investigate whether percutaneous access of the common femoral artery (CFA) with a percutaneous closure device would decrease the number of SSIs compared to

Both known prerequisites for a surgical site infection (SSI) are a breach through the continuity of the skin and the introduction of (pathogenic) microorganisms into the wound..

Er is meer kennis nodig over alle micro-organismen die aanwezig zijn in de liesregio, ook in de lymfeklieren en de vaatwand, zodat we in staat zijn om de complexe interactie

Jullie hebben me altijd gesteund al voor het idee begon van een promotie. En nu doen jullie dat